Hantavirus infections in Italy: not reported doesn't mean inexistent.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
02 09 2021
Historique:
received: 19 09 2020
accepted: 21 09 2020
entrez: 6 9 2021
pubmed: 7 9 2021
medline: 21 9 2021
Statut: epublish

Résumé

Hantaviruses can cause serious human diseases including hemorrhagic fever with renal syndrome (HFRS) and Hantavirus Cardiopulmonary Syndrome (HCPS). European Hantavirus are usually associated with HFRS, and their geographical distribution mirrors the ecology of reservoir host species. Epidemiology of HFRS is well-studied in Western Europe, but data from Italy are fragmentary. We searched into two different databases (PubMed and EMBASE), focusing on studies reporting the prevalence of Hantaviruses in Italy. Data were extracted using a standardized assessment form, and results of the analyses were systematically reported, summarized and compared. We identified a total of 18 articles, including 12 reports (total population: 5,336 subjects, 1981-2019) and 6 case reports (1984-2019). In total, 200 subjects exhibited some degree of seropositivity, with a pooled seroprevalence of 1.7% (95% confidence interval 0.7%-4.0%) in the general population. Higher occurrence was reported in selected subgroups, i.e. acute (28.7%, 95%CI 22.1-36.2) and chronic (6.6%, 95%CI 4.7-9.1) renal failure, forestry workers (3.0%, 95%CI 1.4-6.5, actual range 0.0 to 10.8%). In the last decade, no human cases of hantavirus infection have been officially reported in Italy. However, our analysis stresses the actual occurrence of Hantavirus among general population and in selected population groups. Further studies on hantavirus infection rates in reservoir host species (rodents, shrews, and bats) and virus transmission to humans are needed to prevent outbreaks in the future.

Sections du résumé

BACKGROUND
Hantaviruses can cause serious human diseases including hemorrhagic fever with renal syndrome (HFRS) and Hantavirus Cardiopulmonary Syndrome (HCPS). European Hantavirus are usually associated with HFRS, and their geographical distribution mirrors the ecology of reservoir host species. Epidemiology of HFRS is well-studied in Western Europe, but data from Italy are fragmentary.
METHODS
We searched into two different databases (PubMed and EMBASE), focusing on studies reporting the prevalence of Hantaviruses in Italy. Data were extracted using a standardized assessment form, and results of the analyses were systematically reported, summarized and compared.
RESULTS
We identified a total of 18 articles, including 12 reports (total population: 5,336 subjects, 1981-2019) and 6 case reports (1984-2019). In total, 200 subjects exhibited some degree of seropositivity, with a pooled seroprevalence of 1.7% (95% confidence interval 0.7%-4.0%) in the general population. Higher occurrence was reported in selected subgroups, i.e. acute (28.7%, 95%CI 22.1-36.2) and chronic (6.6%, 95%CI 4.7-9.1) renal failure, forestry workers (3.0%, 95%CI 1.4-6.5, actual range 0.0 to 10.8%).
CONCLUSIONS
In the last decade, no human cases of hantavirus infection have been officially reported in Italy. However, our analysis stresses the actual occurrence of Hantavirus among general population and in selected population groups. Further studies on hantavirus infection rates in reservoir host species (rodents, shrews, and bats) and virus transmission to humans are needed to prevent outbreaks in the future.

Identifiants

pubmed: 34487097
doi: 10.23750/abm.v92i4.10661
pmc: PMC8477108
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2021324

Références

Int J Occup Med Environ Health. 2018 Jan 15;31(3):317-331
pubmed: 29165429
Transbound Emerg Dis. 2020 Mar;67(2):502-509
pubmed: 31674714
Swiss Med Wkly. 2007 Jan 13;137(1-2):21-6
pubmed: 17299664
Med Microbiol Immunol. 2011 Nov;200(4):263-8
pubmed: 21611907
Lancet Infect Dis. 2003 Oct;3(10):653-61
pubmed: 14522264
Viruses. 2019 Jul 24;11(8):
pubmed: 31344894
J Infect Dev Ctries. 2008 Feb 01;2(1):3-23
pubmed: 19736383
mSphere. 2020 Jul 15;5(4):
pubmed: 32669473
Int J Environ Res Public Health. 2019 Feb 25;16(4):
pubmed: 30823571
Scand J Work Environ Health. 1998 Apr;24(2):104-8
pubmed: 9630057
Euro Surveill. 2013 Dec 12;18(50):20660
pubmed: 24342520
Zentralbl Arbeitsmed Arbeitsschutz Ergon. 2018;68(2):94-97
pubmed: 32288306
Epidemiol Infect. 2006 Aug;134(4):830-6
pubmed: 16371172
Euro Surveill. 2019 Aug;24(32):
pubmed: 31411134
J Travel Med. 2002 Nov-Dec;9(6):326-9
pubmed: 12962589
Clin Microbiol Infect. 2019 Apr;21S:e6-e16
pubmed: 24750436
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):305-13
pubmed: 7649193
New Microbiol. 2013 Jan;36(1):103-5
pubmed: 23435824
BMJ Case Rep. 2014 Jul 17;2014:
pubmed: 25035452
Emerg Infect Dis. 2010 Oct;16(10):1584-6
pubmed: 20875284
Euro Surveill. 2011 Sep 08;16(36):
pubmed: 21924118
Viruses. 2019 Jul 23;11(7):
pubmed: 31340455
Expert Rev Anti Infect Ther. 2009 Mar;7(2):205-17
pubmed: 19254169
Lancet. 1991 Nov 16;338(8777):1277
pubmed: 1682675
Ecohealth. 2018 Sep;15(3):695-704
pubmed: 29796719
Epidemiol Infect. 1995 Apr;114(2):373-83
pubmed: 7705497
J Agromedicine. 2020 Jan;25(1):73-85
pubmed: 31456505
Eur J Epidemiol. 1994 Jun;10(3):349-51
pubmed: 7859849
Ind Health. 2020 Apr 2;58(2):182-192
pubmed: 31548469
Clin Microbiol Rev. 2010 Apr;23(2):412-41
pubmed: 20375360
Front Microbiol. 2020 Jan 30;10:2989
pubmed: 32082263
Viruses. 2019 Aug 27;11(9):
pubmed: 31461937
Eur J Epidemiol. 1987 Sep;3(3):295-301
pubmed: 2888688
Ann Ig. 2017 Jul-Aug;29(4):239-255
pubmed: 28569334
Acta Biomed. 2020 Dec 23;90(4):457-467
pubmed: 31910170
BMC Public Health. 2011 May 23;11:376
pubmed: 21605460
BMC Infect Dis. 2020 Feb 4;20(1):103
pubmed: 32019494
Eur J Epidemiol. 1992 Jan;8(1):98-102
pubmed: 1349288
Gesundheitswesen. 2001 Feb;63(2):107-12
pubmed: 11285748
Am J Trop Med Hyg. 1993 Jan;48(1):20-5
pubmed: 8093990
PeerJ. 2018 Feb 01;6:e4255
pubmed: 29404206
Am J Trop Med Hyg. 2009 Feb;80(2):279-85
pubmed: 19190227
J Agromedicine. 2002;8(2):95-111
pubmed: 12853275
Semin Nephrol. 2019 May;39(3):278-283
pubmed: 31054627
Epidemiol Infect. 2010 Oct;138(10):1484-92
pubmed: 20109263
Trans R Soc Trop Med Hyg. 1991 Nov-Dec;85(6):789
pubmed: 1686948
Vector Borne Zoonotic Dis. 2010 Aug;10(6):549-61
pubmed: 20795916

Auteurs

Matteo Riccò (M)

AUSL - IRCCS di Reggio Emilia, Servizio di Prevenzione e Sicurezza negli ambienti di Lavoro (SPSAL), Via Amendola n.2, I-42122 Reggio Emilia (RE), Italy . mricco2000@gmail.com.

Simona Peruzzi (S)

AUSL-IRCCS di Reggio Emilia, Laboratorio Analisi Chimico Cliniche e Microbiologiche, Ospedale Civile di Guastalla, Via Donatori di Sangue n.1, I-42016 Guastalla (RE), Italy;. simona.peruzzi@ausl.re.it.

Silvia Ranzieri (S)

University of Parma, Department of Medicine and Surgery, School of Occupational Medicine; Via Gramsci n.14, 43126; Parma (PR), Italy. silvia.ranzieri@unipr.it.

Federica Balzarini (F)

University "Vita e Salute", San Raffaele Hospital; Via Olgettina n. 58, 20132; Milan (MI), Italy. federica.balzarini@gmail.com.

Marina Valente (M)

University of Parma, Department of Medicine and Surgery, School of General Surgery; Via Gramsci n.14, 43126; Parma (PR), Italy . valentemarina.bis@gmail.com.

Federico Marchesi (F)

University of Parma, Department of Medicine and Surgery, School of General Surgery; Via Gramsci n.14, 43126; Parma (PR), Italy . federico.marchesi@unipr.it.

Nicola Luigi Bragazzi (NL)

Laboratory for Industrial and Applied Mathematics (LIAM), Department of Mathematics and Statistics, University of York, Toronto (ON), Canada. bragazzi@yorku.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH